Catherine Kanter named speech-language pathologist of the year

“I then found in speech-language pathology a wonderful marriage of my love for language and communication and helping individuals with disabilities, and came to UW-Madison to complete my graduate degree,” says Kanter, who has worked as a full-time speech-language pathologist, or SLP, at the Waisman Center since June 2018.

Mancheski Foundation funds next-gen research on Down syndrome and Alzheimer’s

A gift from the Mancheski Foundation continues to provide integral support to doctoral student Matthew Zammit as he furthers his research on the progression of Alzheimer’s disease in individuals with Down syndrome. Zammit is beginning …

Clinical trial for Ebola vaccine developed at UW–Madison underway in Japan

As of this week, a phase one clinical trial to test a potential new Ebola vaccine developed by researchers at the University of Wisconsin–Madison is underway in Japan. Fifteen healthy young men* will receive two doses of the experimental vaccine. If the first group tolerates the vaccine, an additional group of up to 20 volunteers will receive a higher dose of the vaccine.